| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8453294 | Leukemia Research | 2018 | 4 Pages |
Abstract
We found that plasma miR-155 expression was significantly up-regulated in patients with DLBCL (median expression value: 4.29, range: 1.52-27.86) compared to healthy individuals (median expression value: 2.14, range: 0.29-10.56, Pâ¯<â¯0.002). Moreover, DLBCL cases with an elevated level of miR-155 had shorter overall survival (median 9 vs. 13 months, Pâ¯=â¯0.043) than those with a lower miR-155 expression.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Mohammad Ahmadvand, Mahsa Eskandari, Hossein Pashaiefar, Marjan Yaghmaie, Saba Manoochehrabadi, Golnaz Khakpour, Fatemeh Sheikhsaran, Mostafa Montazer Zohour,